Titan Pharmaceuticals, Inc. (de)

NASDAQ:TTNP  
7.09
+0.12 (+1.72%)
6:05:31 PM EDT: $6.77 -0.32 (-4.51%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Titan Pharmaceuticals, Inc. (de) Stock, NASDAQ:TTNP

400 Oyster Point Boulevard, Suite 505, South San Francisco, California 94080-1958
United States of America
Phone: +1.650.244.4990
Number of Employees: 4
http://www.titanpharm.com

Description

Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, proNeura. Its lead product is probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction. The company was founded by Louis R. Bucalo on February 7, 1992 and is headquartered in South San Francisco, CA.